» Articles » PMID: 17418634

Comparative Study on Digestive Lipase Activities on the Self Emulsifying Excipient Labrasol, Medium Chain Glycerides and PEG Esters

Overview
Specialties Biochemistry
Biophysics
Date 2007 Apr 10
PMID 17418634
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Labrasol is a lipid-based self-emulsifying excipient used in the preparation of lipophilic drugs intended for oral delivery. It is mainly composed of PEG esters and glycerides with medium acyl chains, which are potential substrates for digestive lipases. The hydrolysis of Labrasol by porcine pancreatic extracts, human pancreatic juice and several purified digestive lipases was investigated in the present study. Classical human pancreatic lipase (HPL) and porcine pancreatic lipase, which are the main lipases involved in the digestion of dietary triglycerides, showed very low levels of activity on the entire Labrasol excipient as well as on separated fractions of glycerides and PEG esters. On the other hand, gastric lipase, pancreatic lipase-related protein 2 (PLRP2) and carboxyl ester hydrolase (CEH) showed high specific activities on Labrasol. These lipases were found to hydrolyze the main components of Labrasol (PEG esters and monoglycerides) used as individual substrates, whereas these esters were found to be poor substrates for HPL. The lipolytic activity of pancreatic extracts and human pancreatic juice on Labrasol(R) is therefore mainly due to the combined action of CEH and PLRP2. These two pancreatic enzymes, together with gastric lipase, are probably the main enzymes involved in the in vivo lipolysis of Labrasol taken orally.

Citing Articles

Intrinsic lipolysis rate for systematic design of lipid-based formulations.

Jacobsen A, Kabedev A, Sinko P, Palm J, Bergstrom C, Teleki A Drug Deliv Transl Res. 2022; 13(5):1288-1304.

PMID: 36209313 PMC: 10102029. DOI: 10.1007/s13346-022-01246-y.


Enhanced oral absorption of insulin: hydrophobic ion pairing and a self-microemulsifying drug delivery system using a D-optimal mixture design.

Goo Y, Lee S, Choi J, Kim M, Sin G, Hong S Drug Deliv. 2022; 29(1):2831-2845.

PMID: 36050870 PMC: 9448375. DOI: 10.1080/10717544.2022.2118399.


Oil-Based Delivery Control Release System Targeted to the Later Part of the Gastrointestinal Tract-A Mechanistic Study.

Zhang L, Wahlgren M, Bergenstahl B Pharmaceutics. 2022; 14(5).

PMID: 35631482 PMC: 9144740. DOI: 10.3390/pharmaceutics14050896.


Scrutinizing the Feasibility of Nonionic Surfactants to Form Isotropic Bicelles of Curcumin: a Potential Antiviral Candidate Against COVID-19.

Mahmoud D, Bakr M, Al-Karmalawy A, Moatasim Y, El Taweel A, Mostafa A AAPS PharmSciTech. 2021; 23(1):44.

PMID: 34966978 PMC: 8716085. DOI: 10.1208/s12249-021-02197-2.


Investigation of Self-Emulsifying Drug-Delivery System Interaction with a Biomimetic Membrane under Conditions Relevant to the Small Intestine.

Hedge O, Hook F, Joyce P, Bergstrom C Langmuir. 2021; 37(33):10200-10213.

PMID: 34379976 PMC: 8388123. DOI: 10.1021/acs.langmuir.1c01689.